RHHBY - Dispute with G.O.P senators could jeopardize additional finding for COVID-19 treatments

A disagreement between Republican senators and the White House over funding for COVID-19 therapeutics and vaccines could imperil the Biden administration’s efforts to provide pandemic relief for Americans this year. The dispute stems from the level of transparency provided by the government on how it spent over $4 trillion COVID-19 relief funds authorized by the Congress. The administration has sought another $22.5 billion for future needs in vaccines, oral antivirals, and monoclonal antibodies, testing, and also global vaccination efforts. “This is an urgent request,” Jen Psaki, the White House press secretary, said Friday, adding that current supplies of monoclonal antibodies will be exhausted by May, and stocks of oral antivirals will run out in September without additional purchases. However, a group of three dozen Republican senators, including Senate Minority Leader Mitch McConnell (R-Ky.), informed the White House last week, they would not consider additional funding without more details on how

For further details see:

Dispute with G.O.P senators could jeopardize additional finding for COVID-19 treatments